Abstract: A display device includes a first substrate including a light emitting area and a non-light emitting area, a first pixel electrode disposed on the light emitting area of the first substrate, a pixel defining layer disposed on the non-light emitting area of the first substrate and the first pixel electrode, a light emitting structure disposed on the first pixel electrode and including quantum dots, and a common electrode covering the light emitting structure and the pixel defining layer, wherein the pixel defining layer includes an inorganic insulating material layer including a fluorine-based material.

Abstract: According to an embodiment of the disclosure, a display device is provided. The display device includes a base layer including a display area and a peripheral area, a light emitting element disposed in the display area and including a first electrode, a second electrode, and a light emitting part disposed between the first electrode and the second electrode, an electrode disconnection member disposed in the peripheral area, and an electrode portion disposed adjacent to the electrode disconnection member. The electrode disconnection member includes a reverse-taper member surrounding an area in a plan view. The reverse-taper member includes an inner edge facing the area. The electrode portion includes a first electrode portion disposed in the area and a second electrode portion disposed on an upper surface of the reverse-taper member along the inner edge. The first electrode portion and the second electrode portion are physically spaced apart from each other.

Abstract: A display device and a method of fabricating the same are provided. The display device comprises a substrate, a transistor disposed on the substrate, a via layer disposed over the transistor and including a contact hole extending to the transistor, a pixel electrode disposed on the via layer and connected to the transistor through the contact hole, a first bank layer disposed on the pixel electrode and extending in a first direction, and a second bank layer extended in a second direction crossing the first direction, a light emitting layer disposed on the pixel electrode, and a common electrode disposed on the light emitting layer, wherein the second bank layer comprises a first region that does not overlap the contact hole and a second region that overlaps the contact hole, and wherein a width of the second region is greater than a width of the first region.

Abstract: A light emitting element includes a first surface corresponding to an end of the light emitting element, a second surface corresponding to another end of the light emitting element, a first semiconductor layer adjacent to the first surface, the first semiconductor layer including a first type of semiconductor, a second semiconductor layer adjacent to the second surface, the second semiconductor layer including a second type of semiconductor different from the first type of semiconductor, and an active layer disposed between the first semiconductor layer and the second semiconductor layer. An area of the first surface is larger than an area of the second surface, and a distance between the first surface and the second surface is shorter than a length defined by the first surface.

Abstract: A display device according to an embodiment includes: a substrate including a display area, a dummy area, and a peripheral area; a passivation layer positioned in the display area, the dummy region, and the peripheral area of the substrate; a first adhesive auxiliary layer positioned on the passivation layer and positioned in the dummy region; a dummy pixel defining layer positioned on the first adhesive auxiliary layer and including a hydrophobic material; a second adhesive auxiliary layer positioned on the passivation layer, positioned in the peripheral area, and including a lateral side contacting the dummy pixel defining layer; a common voltage transmitter positioned in the peripheral area; and a common electrode connected to the common voltage transmitter, and positioned on the second adhesive auxiliary layer and the dummy pixel defining layer.

Abstract: A display device includes a first substrate including an emission area and a non-emission area; a first pixel electrode positioned on the emission area of the first substrate; a first light emitting structure positioned on the first pixel electrode and including quantum dots; a pixel defining layer positioned on the non-emission area of the first substrate and positioned on the first pixel electrode; a common electrode covering the first light emitting structure and the pixel defining layer; and an encapsulation structure positioned on the common electrode and in contact with the common electrode such that the encapsulation structure overlaps the non-emission area. The encapsulation structure may include a second substrate and a hydrogen donor layer positioned between the second substrate and the common electrode. The hydrogen donor layer may overlap the emission area and may be in contact with or spaced apart from the common electrode.

Abstract: A for fabricating a semiconductor device comprises forming a mask layer on a substrate, the mask layer defining a through hole that exposes an upper surface of the substrate, the mask layer comprising a first mask layer and a second mask layer, wherein the second mask layer is between the substrate and the first mask layer, and wherein the second mask layer comprises carbon. The method includes forming a liner layer on side walls of the through hole inside the second mask layer.

Abstract: The present invention relates to a sulfate crystal form of a compound represented by formula 1, a method of producing same, and a pharmaceutical composition comprising same. The sulfate crystal form of the compound represented by formula 1 of the present invention may be characterized by an XRPD pattern, a DSC profile, and/or a TGA profile.

Abstract: The present invention relates to a co-crystal of a compound represented by chemical formula 1 and vanillin, a method for preparing same, and a pharmaceutical composition comprising same. The co-crystal of the compound represented by chemical formula 1 and vanillin of the present invention has excellent chemical and physical stability and is characterized by the XRD pattern, DSC profile, and/or TGA profile.

Abstract: The present invention relates to a crystal form VII of a compound represented by chemical formula 1, a method for preparing same, and a pharmaceutical composition comprising same. The crystal form VII of the compound represented by chemical formula 1, according to the present invention, can be characterized by an XRD pattern, a DSC profile, and/or a TGA profile.

Abstract: The present invention relates to a crystalline form V of a compound represented by chemical formula 1, a method for preparing same, and a pharmaceutical composition comprising same. Crystalline form V of the compound represented by chemical formula 1 according to the present invention may be characterized by an XRD pattern, a DSC profile, and/or a TGA profile.

Abstract: The present invention relates to a crystal form IV of organic acid salts of a compound represented by chemical formula 1, a preparation method thereof, and a pharmaceutical composition comprising same. The crystal form IV of organic acid salts of the compound represented by chemical formula 1 of the present invention may be characterized by an XRPD pattern, a DSC profile, and/or a TGA profile.

Abstract: The present invention relates to a crystalline form of a sphingosine-1-phosphate receptor agonist and, more particularly, to a crystalline form0- of 1-[1-chloro-6-(3-chloro-1-isopropyl-1H-indazol-5-ylmethoxy)-3,4-dihydro-naphthalen-2-ylmethyl]-piperidine-4-carboxylic acid of chemical formula 1 or a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to an amorphous compound represented by formula 1, a method for preparing the same, and a pharmaceutical composition comprising the same. The amorphous compound represented by formula 1 of the present invention may be characterized by XPRD patterns, DSC profiles, and/or a NMR spectrum.

Abstract: The present invention relates to a crystalline form III represented by formula 1, a method for preparing the same, and a pharmaceutical composition comprising the same. The crystalline form III represented by formula 1 of the present invention may be characterized by XRPD patterns, TG/DTA profiles, an NMR spectrum, and/or DVS profiles.

Abstract: The present invention relates to a crystalline form II represented by formula 1, a method for preparing the same, and a pharmaceutical composition comprising the same. The crystalline form II represented by formula 1 of the present invention may be characterized by XRPD patterns, DSC profiles, TGA profiles, and/or DVS profiles.

Abstract: The present invention relates to a crystalline form I represented by formula 1, a method for preparing the same, and a pharmaceutical composition comprising the same. The crystalline form I represented by formula 1 of the present invention may be characterized by XRPD patterns, DSC profiles, TGA profiles, and/or DVS profiles.

Abstract: The present invention relates to a crystalline form IV represented by formula 1, a method for preparing the same, and a pharmaceutical composition comprising the same. The crystalline form IV represented by formula 1 of the present invention may be characterized by XRD patterns, DSC profiles, and/or TGA profiles.

Abstract: The present invention relates to a crystalline form II represented by formula 1, a method for preparing the same, and a pharmaceutical composition comprising the same. The crystalline form II represented by formula 1 of the present invention may be characterized by XRD patterns, DSC profiles, and/or TGA profiles.

Abstract: The present invention relates to a crystalline form III represented by formula 1, a method for preparing the same, and a pharmaceutical composition comprising the same. The crystalline form III represented by formula 1 of the present invention may be characterized by XRD patterns, DSC profiles, and/or TGA profiles.